IL11 and endometrium neoplasm: Exogenous IL11 promoted AN3CA subcutaneous xenograft endometrial tumour growth in vivo andIL11Rα inhibition and doxorubicin combinantation treatment enhanced apoptosis in AN3CA cells in vitro and impaired high grade endometrial tumourigenesis in vivo.